Docetaxel as Single-Agent Treatment in Elderly Patients with Advanced Breast Cancer

Author： Lorenzo I. Constenla M. Palacios P. García-Arroyo F.R. Fernández I. Campos B. Salgado L. Carrete N.

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.4, 2005-01, pp. : 249-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D Sarkar Tarun Hutcheon Andrew W

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite

A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer

By Moulder Stacy Dhillon Navneet Ng Chaan Hong David Wheler Jennifer Naing Aung Tse Susan La Paglia Amy Dorr Robert Hersh Evan Boytim Michelle Kurzrock Razelle

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 634-640

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel Mavroudis Dimitris Georgoulias Vassilis

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Advanced breast cancer - a NICE result for docetaxel

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite